SCHEMBL26558114

SCHEMBL26558114

CC(C)[Si](O[C@@H]1[C@@H](COC(=O)OCc2ccccc2)OC(=O)[C@@]1(C)O)(C(C)C)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
HSD17B10 Q99714 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ATM Q13315 1/20 0.35
CTSL P07711 2/20 0.35
CTSS P25774 2/20 0.35
CTSK P43235 2/20 0.35
CYP3A4 P08684 6/20 0.34
CYP2C9 P11712 6/20 0.34
TSHR P16473 5/20 0.34
CYP2C19 P33261 5/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NAAA Q02083 4/20 0.34
CYP1A2 P05177 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ELANE P08246 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26558110 0.89 ALDH1A1 (0.37) ALDH1A1HSD17B10CTSLCTSSCTSK
SCHEMBL26558111 0.87 NAAA (0.36) ALDH1A1CYP3A4TSHRMEN1KMT2A
SCHEMBL26558118 0.86 ALDH1A1 (0.34) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL26557776 0.85 ALDH1A1 (0.38) ALDH1A1MAPTCYP3A4CYP2C9CYP2C19
SCHEMBL26558103 0.85 ALDH1A1 (0.35) ALDH1A1HSD17B10MAPTHPGDATM
SCHEMBL26558133 0.84 NAAA (0.38) ALDH1A1HSD17B10CTSLCTSSCTSK
SCHEMBL26558121 0.84 NAAA (0.33) ALDH1A1HSD17B10MEN1KMT2ANAAA
SCHEMBL26558138 0.84 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL26558150 0.82 NAAA (0.38) ALDH1A1HSD17B10CTSLCTSSCTSK
SCHEMBL26558093 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331751-A1 STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331751-A1 STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES NUDT1, PNP, ATIC ALDH1A1 946/4885HSD17B10 4470/4885MAPT 3657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.